Hypercom POS Transaction Technology, SiVault Systems’ Signature

PHOENIX and NEW YORK, August 11, 2004–Hypercom Corporation (NYSE: HYC) and SiVault Systems Inc. (OTCBB: STVL. OB) today announced a strategic partnership that will combine SiVault Systems’ end-to-end signature verification technology with Hypercom’s point-of-transaction card payment technology in a solution designed to significantly improve the authentication and fulfillment of medical prescriptions.

Deployment of the Hypercom-SiVault solution will give pharmacy operations, doctors and insurers a powerful new solution to help confirm the authorized fulfillment of prescriptions, and in doing so, help stem prescription fraud in a rapidly expanding market. Between 2003 and 2010, the number of prescriptions dispensed is expected to increase by 47%, growing from 3.22 billion in 2003 to nearly 4.5 billion in 2010, according to published industry reports.

“Hypercom and SiVault Systems have created a prescription-fulfillment solution that protects consumers, doctors, pharmacies, and insurance providers when prescribing and delivering medicine. Confirmation that the authorized person received the filled prescription will be assured with our combined signature capture and verification technologies,” said Emilian Elefteratos, SiVault Systems chief executive officer and president. “Fraud, errors and administrative costs should be significantly reduced for our customers in the retail pharmacy segment and other healthcare areas where prescriptions are filled and transacted.”

To achieve this major advancement in ensuring prescription fulfillment, global transaction technology leader Hypercom is utilizing its new compact, high speed, high performance Optimum L4100 multi-application signature capture card payment terminal specifically designed to speed the check-out lines at multi-lane retailers worldwide. SiVault Systems is using its prescription authentication and remote storage service software suite. The combined technology solution is market-ready for small to large pharmacy operations, including multi-lane, and medical offices.

“This new strategic partnership with SiVault demonstrates, again, how Hypercom is leveraging and extending its experience in electronic payments into new avenues and opportunities that go far beyond traditional credit and debit, said Guilherme Blumenthal, executive vice president, Sales and Operations, Hypercom Corporation. “This intelligent integration of Hypercom and SiVault technology will help deliver added security, speed and convenience to pharmacies and healthcare providers, and the consumers they serve.”

SiVault Systems Solution: Reduces Fraud, Errors, Administrative Costs While Improving Transaction Security

SiVault Systems’ prescription authentication and remote storage service is targeted at doctors and pharmacists. It provides a cryptographically secure infrastructure for establishing validity of electronic prescriptions based on authenticating biometric data. The authentication and remote storage reduces prescription fraud and minimizes prescription mistakes. The company uses a proprietary, central repository for signed and validated prescriptions.

The company’s patented technology captures more than a picture of a signature, it captures the “digital DNA” that lies underneath it, that is, how you uniquely sign your name–such as speed, pressure and breakage point. The technology is an attractive alternative to passwords, PINs and keys and a powerful tool for paperless transactions.

SiVault Systems uses many ways to capture signatures of doctors working in hospitals and private practices, such as signature pads, pen computers, and PDAs. As soon as the signature is authenticated, a secure prescription with a unique number is created and centrally stored by SiVault Systems. A hardcopy of the prescription can be given to a patient, or an electronic prescription can be routed directly to a pharmacy.

Functionality of SiVault Systems’ solution includes signature and prescription authentication, prescription storage and delivery, security and encryption, as well as fine-grained access control to different parts of prescription data. The system also stores information about filled prescriptions and tracks precisely when patients receive them.

SiVault Systems solution easily integrates with existing pharmacy systems. It also is capable of generating hardcopies of electronic prescriptions that can be used by patients in any pharmacy, regardless of whether it is connected to SiVault Systems electronically or not.

Optimum L4100: Powerful, Intelligent Global Transaction Technology

Hypercom’s new high speed, high performance Optimum L4100 signature capture card payment terminal features the powerful Intel® PXA255 processor for optimal low power consumption, high performance processing and industry-leading mW/MIPS performance. Intel technology enables retailers, consumer goods companies and others to deliver faster, crisper communications and vibrant full screen graphics directly to the consumer.

The sleek, compact PED and EMV certified Optimum L4100 features magnetic stripe and smart card readers, a One-Touch consumer interactive 1/4 VGA color touch screen and multiple high-speed communications options. Equally important, Hypercom’s Optimum L4100 supports the entire set of DES requirements, including 3DES Master Session and 3DES DUKPT. The terminal’s innovative in-mold decorating technology lets retailers quickly add their own distinctive branding and colors to the terminal, thereby generating repeat consumer impressions at the point-of-sale.

About SiVault Systems Inc. (http://www.sivault.com)

Founded in 1999, SiVault Systems (OTCBB: SVTL.OB) is a recognized leader in the secure storage and retrieval of signed documents and biometric signature-based authentication for processing of online transactions. SiVault Systems’ services are 100% compliant with regulations and standards in the retail and healthcare industries for authentication, authorization, transmission and storage of data. For more information, visit the companies’ web sites at http://www.sivault.com.

About Hypercom (http://www.hypercom.com)

Celebrating 26 years of technological excellence, innovation, and leadership, Hypercom is a leading global provider of electronic payment solutions that add value at point-of-sale transactions for consumers, merchants, and acquirers, and yield increased profitability for its customers.

Widely recognized as the payment technology innovator, Hypercom delivers comprehensive card payment terminal, network and server solutions that help merchants and financial institutions generate revenues and increased profits.

Headquartered in Phoenix, Arizona, Hypercom’s card payment terminal, network, and server solutions are leading the transformation of electronic payments in more than 100 countries.

Hypercom is a registered trademark of Hypercom Corporation. Optimum and Design is a trademark of Hypercom Corporation. Intel is a registered trademark of Intel Corporation. All other products or services mentioned in this document are trademarks, service marks, registered trademarks or registered service marks of their respective owners. This press release includes statements that may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including market acceptance of new product applications and future sales, revenues. These forward-looking statements are based on management’s current expectations and beliefs and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward-looking statements include, industry, competitive and technological changes; the loss of, and failure to replace any significant customers; the composition, timing and size of orders from and shipments to major customers; inventory obsolescence; market acceptance of new products and services; the performance of suppliers and subcontractors; risks associated with international operations and foreign currency fluctuations; the state of the U.S. and global economies in general and other risks detailed in our filings with the Securities and Exchange Commission, including the Company’s most recent 10-K and subsequent 10-Qs. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.